The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

It's been a while since Clarkson nabbed a movie role as full-scale and invigorating as the one she has in "Lilly," a ...

Writer and director Rachel Feldman reflects on her heroine Lilly Ledbetter and all the mothers that helped bring her biopic ...

President Donald Trump's second term in office has been challenging for investors, at least so far. Trump imposed sweeping ...

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...